Mack Gill

Mack Gill

Directeur/Membre du Conseil chez ALTIMMUNE, INC.

Fortune : 19 951 $ au 30/04/2024

72 ans
Health Technology
Technology Services
Finance

Profil

John M.
Gill
founded TetraLogic Pharmaceuticals Corp.
in 2001, where he worked as Director from 2013 to 2014.
Dr. Gill also currently works at Millennium Information Technologies Ltd., as Chief Executive Officer from 2013, Altimmune, Inc., as Independent Director from 2004, and Torstone Technology Ltd., as Chief Operating Officer.
Dr. Gill also formerly worked at PharmAthene, Inc., as President, Chief Executive Officer & Director from 2015 to 2017, 3-Dimensional Pharmaceuticals, Inc., as Chief Financial Officer, Director & Executive VP, PharmAthene, Inc., as Director in 2007, Theraclone Sciences, Inc., as Director, The Biotechnology Greenhouse Corp.
of Southeastern PA, as Director, Ben Franklin Technology Partners, as Director, FIS Capital Markets US LLC (Pennsylvania), as SVP-Corporate Development & Strategy, GSK Equity Investments Ltd., as President, US Department of Defense (District of Columbia), as Principal from 1971 to 1973, Smithkline & French Laboratories US, Inc., as Chief Operating Officer, SunGard Financial Systems, as President-Global Technology, Nova Pharmaceutical Corp., as Chief Operating Officer, GlaxoSmithKline LLC, as VP-Research & Development Operations, and Sungard Global Services France SA, as President in 2011.
Dr. Gill received his undergraduate degree in 1975 from Rutgers State University of New Jersey, graduate degree from Yale University, and undergraduate degree from the University of British Columbia.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
22/03/2024 2 771 ( 0,00% ) 19 951 $ 30/04/2024

Postes actifs de Mack Gill

SociétésPosteDébut
ALTIMMUNE, INC. Directeur/Membre du Conseil 01/08/2004
Directeur Général 23/05/2013
Directeur des opérations -
Tous les postes actifs de Mack Gill

Anciens postes connus de Mack Gill

SociétésPosteFin
Directeur Général 01/05/2017
TETRALOGIC PHARMACEUTICALS CORPORATION Fondateur 29/01/2014
President 01/03/2011
Directeur/Membre du Conseil 30/04/2008
Directeur/Membre du Conseil 03/08/2007
Voir l'expérience en détail de Mack Gill

Formation de Mack Gill

Rutgers State University of New Jersey Undergraduate Degree
Yale University Graduate Degree
University of British Columbia Undergraduate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Mack Gill

Relations

100 +

Relations au 1er degré

21

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées2
TETRALOGIC PHARMACEUTICALS CORPORATION

Health Technology

ALTIMMUNE, INC.

Health Technology

Entreprise privées16

Technology Services

Health Technology

Health Technology

Commercial Services

Technology Services

Finance

Finance

US Department of Defense (District of Columbia)

Government

Finance

Health Technology

Smithkline & French Laboratories US, Inc.

Technology Services

Nova Pharmaceutical Corp.

Health Technology

Technology Services

Technology Services

Voir les connexions sociétés